Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination

The coronavirus 2019 (COVID-19) pandemic is expected to linger. Decisions regarding initiation or continuation of disease-modifying therapy for multiple sclerosis have to consider the potential relevance to the pandemic. Understanding the mechanism of action and the possible idiosyncratic effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Crystal, Kar, Indrani, Chen, Claire Kaori, Sau, Crystal, Woodson, Sophia, Serra, Alessandro, Abboud, Hesham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417850/
https://www.ncbi.nlm.nih.gov/pubmed/32780300
http://dx.doi.org/10.1007/s40263-020-00756-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417850/
https://www.ncbi.nlm.nih.gov/pubmed/32780300
http://dx.doi.org/10.1007/s40263-020-00756-y

Ejemplares similares